Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

April 5, 2023
Join the Hawaii Society of Clinical Oncology for a discussion with Dr. Velotta, UCSF Clinical Assistant Professor in the Department of Surgery at Kaiser Permanente. Dr. Velotta will go into detail about the Contemporary Surgical Management for Esophageal Cancer in 2023 and Beyond. Jeffrey Velotta, MD Thoracic Surgery, UCSF Clinical Assistant Professor Department of Surgery Kaiser Permanente 3660 …
The rising costs of anti-cancer treatment in the United States have placed adolescents and young adults with cancer at an increased risk for financial toxicity.
Hear suggestions for how to reduce financial hurdles and increase access to cancer diagnostics.
April 4, 2023
Join the Hawaii Society of Clinical Oncology for a discussion with Dr. Velotta, UCSF Clinical Assistant Professor in the Department of Surgery at Kaiser Permanente. Dr. Velotta will go into detail about the Contemporary Surgical Management for Esophageal Cancer in 2023 and Beyond. Jeffrey Velotta, MD Thoracic Surgery, UCSF Clinical Assistant Professor Department of Surgery Kaiser Permanente 3660 …
ASSOCIATION OF COMMUNITY CANCER CENTERS 1 An Innovative Approach to Navigating Patients Through Cancer Diagnostics ASSOCIATION OF COMMUNITY CANCER CENTERS W hen ACCC began its journey to explore how cancer programs and practices around the country are meeting the demands of increased precision medicine testing, the concept of precision medicine stewards—a nuanced approach …
ASSOCIATION OF COMMUNITY CANCER CENTERS 1 What is Biomarker Testing? ASSOCIATION OF COMMUNITY CANCER CENTERS A Financial Advocate’s Guide to Biomarker Testing in Cancer Patients with cancer often undergo biomarker testing to determine if a targeted therapy may be an effective treatment option. Biomarkers may include things like genes, proteins, and other molecular …
March 31, 2023
The Louisiana Oncology Society (LOS) 2023 Cancer Congress will be held on March 31 from 7:00 AM - 4:00 PM CDT to April 1 from 7:30 AM - 2:45 PM CDT. New Orleans Convention Center 900 Convention Center Boulevard New Orleans, LA 70130 In its third year, the Louisiana Oncology Society (LOS) Cancer Congress unites oncology champions from across the state to contribute to important conversation about the …
In recognition of March as social work month, ACCCBuzz discusses the value of social workers as a member of the multidisciplinary cancer care team with Sarah Conning, MSW, LCSW, OSW-C, APHSW-C.
Faculty, Staff, and Planners’ Disclosures The following individuals have no relevant financial relationships with ineligible companies to disclose: John Cole, MD; Michelle Loch, MD; Caitlin Lopes, MD; Catherine B. Oliver; Thomas Reske, MD; Adam Salup, MD; Ashley Staton, MD; Julie Stokes; and the staffs of the Louisiana Oncology Society and Physicians’ Education Resource®, LLC Faculty …
March 30, 2023
ACL Live at the Moody Theater 310 W. 2nd Street Austin, TX 78701 877.471.4225 Managing lung cancer has become increasingly complicated – reflecting the transformative benefits we see with immunotherapy and targeted therapy. Learn the best way to deliver these drugs from the very investigators leading the research. This two-day CME-event will review the latest advances in lung cancer focused on what …
Advanced Prostate Cancer 2023: New Concepts Oliver Sartor, MD Extraordinary Professor, University of Pretoria Laborde Professor of Cancer Research Medical Director Tulane Cancer Center Tulane Medical School New Orleans, Louisiana 1 Disclosure of Conflicts of Interest Oliver Sartor, MD, has the following financial relationships to disclose: Grant/Research Support …
Nutraceuticals in Oncology Laura Kerns, MPH, RD, CSO, LDN, FAND Senior Clinical Dietitian Ochsner Cancer Institute Relevant Financial Disclosures E n l iv i t y C o rp o ra t io n - R es ea r ch S u p p o r t Timeline Nutraceutical uses with specific cancer types Background Choosing safe products Final thoughts References T o d …
Gynecologic Oncology: What’s Hot Right Now? Amelia Jernigan, MD, FACOG Associate Professor & Director of Gynecologic Oncology LSU Health New Orleans Disclosures I am on the Speaker’s Bureau for AstraZeneca Objectives • Hot new options in: • Endometrial cancer • Cervical Cancer • Ovarian cancer • Delivering more equitable care in gynecologic oncology …
Advancing Diversity, Equity, and Inclusion in Cancer Clinical Trials: Where are We ? John T. Cole MD, FACP Ochsner Cancer Institute Ochsner Health Disclosures: •None Advancing DEI in Cancer Clinical Trials The Problem: Low numbers of minority patients participate in cancer clinical trials Advancing DEI in Cancer Clinical Trials •What is the scope …
State of the art on therapies in CLL 2023 Javier Pinilla-Ibarz, MD, PhD. Senior Member Head of Lymphoma section and Director of Immunotherapy Malignant Hematology Department COI • Janssen/Pharmacyclics, Abbvie, Genentech, AstraZeneca, Pfizer, Beigene and Takeda : Consulting and speaker bureau. • Novartis, Lilly, BMS and Merck: Consulting. Established and …
Pharmacogenomics In Oncology Practice Catherine B. Oliver, PharmD, BCPS, DPLA, CPGx System Director – Clinical Pharmacy Services Ochsner Health Disclosures • No relevant relationships to disclose Learning Objectives • Describe the role of pharmacogenomic testing in medication management • Discuss barriers to and solutions for implementation of pharmacogenomic …
CAR T-cell Therapy: The Past, The Present, and The Future Clark Alsfeld, MD Attending Physician Ochsner Health Disclosure of Conflicts of Interest Consultant – Janssen Biotech; CTI Biopharma Learning Objectives •Understand the current state of CAR T-cell therapy in hematologic malignancies •Know what to expect for CART in the community •Review future directions …
Management of Mantle Cell Lymphoma in the Era of Targeted Therapy Nakhle Saba, MD 2023 Louisiana Cancer Congress Friday March 31, 2023 New Orleans, LA Nakhle Saba, MD has the following financial relationships to disclose: ▪ Consultant: AbbVie ▪ Speaker’s Bureau: AbbVie; Janssen; Pharmacyclics ▪ Advisory Board: AbbVie; ADC Therapeutics,Janssen, Kyowa Kirin, Pharmacyclics …